clinical research benefits

What are clinical trials and how do they work?

Clinical trials help deliver potentially life-saving treatments. Image:  Pexels.

.chakra .wef-spn4bz{transition-property:var(--chakra-transition-property-common);transition-duration:var(--chakra-transition-duration-fast);transition-timing-function:var(--chakra-transition-easing-ease-out);cursor:pointer;text-decoration:none;outline:2px solid transparent;outline-offset:2px;color:inherit;}.chakra .wef-spn4bz:hover,.chakra .wef-spn4bz[data-hover]{text-decoration:underline;}.chakra .wef-spn4bz:focus-visible,.chakra .wef-spn4bz[data-focus-visible]{box-shadow:var(--chakra-shadows-outline);} Kevin Doxzen

Listen to the article

• Clinical trials are designed to determine if a medical, surgical, or behavioural intervention is safe for people.
• There are 420,000 clinical trials, across 221 countries, testing everything from exercise routines to gene therapies.
• Innovative uses of data technologies are improving the speed, costs, and reach of trials.

Scientists are discovering new cures for cancer, Alzheimer’s disease, and other diseases on a weekly basis; or at least that is what news headlines would suggest. Many of these press releases are based on preliminary research in cells or mice, while a majority of novel drugs end up showing no benefit when tested in people. Moving from cells to humans is the start of a highly-regulated and coordinated process called a clinical trial.

What are clinical trials?

Clinical trials are designed to determine whether a medical, surgical, or behavioural intervention is safe and effective for people. Regulators and researchers are continually looking for ways to accelerate the speed and reduce overall costs of clinical trials with the goal of bringing life-saving treatments to patients sooner.

As of September 2022, there were over 420,000 studies registered on ClinicalTrials.gov , a database of privately and publicly funded clinical studies conducted around the world. These studies spanned 221 countries recruiting millions of volunteers worldwide, testing everything from simple behaviours like exercise routines to complex procedures like gene therapies, all following a similar multi-phase process to evaluate their effect on human health.

Discovery to treatment: the clinical trial process

Basic research can often lead to the discovery of new drugs either intentionally or serendipitously. In between basic research and the start of a clinical trial is “ preclinical research ,” which involves lab experiments in cells or animal models to determine whether the drug is useful and if it is toxic before testing in people. This process takes multiple years and ends when researchers submit their data and detailed clinical trial plans to a regulatory agency like the US Food and Drug Administration (FDA).

Clinical trials are conducted in four phases , designed to evaluate a treatment, find the right dosage, and observe any side effects: Phase I usually involves a handful of people and judges a treatment’s safety and side effects; during Phase II and Phase III the number of participants increases and emphasis is given to the treatment’s effectiveness, after which the FDA may grant approval; Phase IV is designed to monitor long-term safety, identifying side effects that might not appear until years later.

While timelines greatly vary, the first three phases of clinical trials can take between 10-15 years to complete, costing companies anywhere from $1-2 million to more than $340 million . This process may appear overly complex for determining something as simple as a drug’s health impact but each step is carefully calculated, including sterile manufacturing practices, ethical patient consent, and clearly defined endpoints and measurements. Yet, even within this strict structure is room to experiment and try out new trial designs, with the goals of improving speed and reducing costs.

Have you read?

8 things you should know about gene therapy, new trial paradigms: increasing speed and decreasing costs.

Approximately 86% of drugs that enter clinical trials do not receive FDA approval. This has significant implications for how pharmaceutical companies approach clinical trials considering that the average total cost of developing a new drug is estimated to be between $2-3 billion . Although clinical trials are highly-regulated processes, innovation in trial design and active engagement with regulators can create flexibility to try new ways of evaluating drugs.

Unlike conventional clinical trials that are fixed and unchanged throughout the study, adaptive trials are flexible and agile, sometimes testing multiple drugs at once . As new data comes in, adaptive trials can drop or add doses, change the trial’s duration, or change the patient populations, which proved critical in quickly responding to the COVID-19 pandemic .

Advances in wearable health devices and AI technologies to gather and store large amounts of real-world, health-related data is impacting the design and execution of clinical trials. Companies are working with regulators to turn this data into real-world evidence , providing new insights into a drug’s safety and long-term effects, which traditional trials may not observe with such detail.

The COVID-19 pandemic has accelerated the adoption of decentralized clinical trials , bringing a proportion of trial activities to the patients rather than bringing patients to a trial site. Virtual technologies and services like telehealth and remote patient monitoring has enabled decentralization, potentially broadening trial access and improving participant diversity , a long-standing issue in drug development.

While momentum is building to improve participant diversity, particularly in the US , for individual clinical trials, reaching communities with some of the highest-disease burdens requires moving clinical trials to other countries.

Making better drugs for more patients

In 2021, the number of trials registered in high-income countries (HICs) was almost 100 times higher than in low-income countries, as reported by the World Health Organization.

Drugs developed in HICs should not be expected to work identically in low- and middle-income countries (LMICs) due to the vast biological diversity across regions. To identify and account for these differences, international collaborations and adaptive clinical trials are being used to create networks of sites across LMICs , helping to pool resources, share expertise, and accelerate data acquisition.

Long-term efforts to build clinical trial capacity (e.g. regulatory systems, manufacturing capabilities) in LMICs will be critical in developing drugs that are safe and effective for specific populations and deliverable within LMIC health systems.

Don't miss any update on this topic

Create a free account and access your personalized content collection with our latest publications and analyses.

License and Republishing

World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.

The views expressed in this article are those of the author alone and not the World Economic Forum.

Stay up to date:

Precision medicine.

.chakra .wef-1v7zi92{margin-top:var(--chakra-space-base);margin-bottom:var(--chakra-space-base);line-height:var(--chakra-lineHeights-base);font-size:var(--chakra-fontSizes-larger);}@media screen and (min-width: 56.5rem){.chakra .wef-1v7zi92{font-size:var(--chakra-fontSizes-large);}} Explore and monitor how .chakra .wef-ugz4zj{margin-top:var(--chakra-space-base);margin-bottom:var(--chakra-space-base);line-height:var(--chakra-lineHeights-base);font-size:var(--chakra-fontSizes-larger);color:var(--chakra-colors-yellow);}@media screen and (min-width: 56.5rem){.chakra .wef-ugz4zj{font-size:var(--chakra-fontSizes-large);}} Precision Medicine is affecting economies, industries and global issues

.chakra .wef-19044xk{margin-top:var(--chakra-space-base);margin-bottom:var(--chakra-space-base);line-height:var(--chakra-lineHeights-base);color:var(--chakra-colors-uplinkBlue);font-size:var(--chakra-fontSizes-larger);}@media screen and (min-width: 56.5rem){.chakra .wef-19044xk{font-size:var(--chakra-fontSizes-large);}} Get involved with our crowdsourced digital platform to deliver impact at scale

The agenda .chakra .wef-dog8kz{margin-top:var(--chakra-space-base);margin-bottom:var(--chakra-space-base);line-height:var(--chakra-lineheights-base);font-weight:var(--chakra-fontweights-normal);} weekly.

A weekly update of the most important issues driving the global agenda

Transforming the understanding and treatment of mental illnesses.

Información en español

• Science News
• Meetings and Events
• Social Media
• Press Resources
• Email Updates
• Innovation Speaker Series

What are the risks and benefits of participating in clinical research?

April 28, 2021

ANNOUNCER: There are risks and benefits to participating in clinical research, much like there are risks and benefits to everyday activities.

Risks to participating in clinical research depend on the type of research. Usually, clinical studies pose the risk of only minor discomfort that lasts for a short time. In some studies, participants take psychological tests; which is a different kind of risk than taking an experimental medication. It is important to speak with the research team to understand the different kinds of risks in a particular study.

All research studies are reviewed for any potential risks and discussed with study volunteers. Possible risks include:

• Unwanted side effects that affect your health
• Having to manage complex medication doses
• The treatment may not make you or other participants better
• You may be randomly assigned to receive a standard treatment or a placebo - which is an inactive pill.
• A large time commitment, including visits to the study site, additional blood tests, and hospital stays.

Benefits to participating in a study include:

• Treatment with experimental or study medications that may not be available anywhere else
• Care from a research team that includes doctors and other health care professionals who are familiar with the most advanced treatments available.
• The opportunity to learn more about an illness and how to manage it .
• The satisfaction of helping others by contributing to medical knowledge or helping to identify possible new treatments.

Thank you for your interest in learning more about clinical research!

• U.S. Department of Health & Human Services

• Virtual Tour
• Staff Directory
• En Español

You are here

Nih clinical research trials and you.

The NIH Clinical Trials and You website is a resource for people who want to learn more about clinical trials. By expanding the below questions, you can read answers to common questions about taking part in a clinical trial. 

What are clinical trials and why do people participate?

Clinical research is medical research that involves people like you. When you volunteer to take part in clinical research, you help doctors and researchers learn more about disease and improve health care for people in the future. Clinical research includes all research that involves people.  Types of clinical research include:

• Epidemiology, which improves the understanding of a disease by studying patterns, causes, and effects of health and disease in specific groups.
• Behavioral, which improves the understanding of human behavior and how it relates to health and disease.
• Health services, which looks at how people access health care providers and health care services, how much care costs, and what happens to patients as a result of this care.
• Clinical trials, which evaluate the effects of an intervention on health outcomes.

What are clinical trials and why would I want to take part?

Clinical trials are part of clinical research and at the heart of all medical advances. Clinical trials look at new ways to prevent, detect, or treat disease. Clinical trials can study:

• New drugs or new combinations of drugs
• New ways of doing surgery
• New medical devices
• New ways to use existing treatments
• New ways to change behaviors to improve health
• New ways to improve the quality of life for people with acute or chronic illnesses.

The goal of clinical trials is to determine if these treatment, prevention, and behavior approaches are safe and effective. People take part in clinical trials for many reasons. Healthy volunteers say they take part to help others and to contribute to moving science forward. People with an illness or disease also take part to help others, but also to possibly receive the newest treatment and to have added (or extra) care and attention from the clinical trial staff. Clinical trials offer hope for many people and a chance to help researchers find better treatments for others in the future

Why is diversity and inclusion important in clinical trials?

People may experience the same disease differently. It’s essential that clinical trials include people with a variety of lived experiences and living conditions, as well as characteristics like race and ethnicity, age, sex, and sexual orientation, so that all communities benefit from scientific advances.

See Diversity & Inclusion in Clinical Trials for more information.

How does the research process work?

The idea for a clinical trial often starts in the lab. After researchers test new treatments or procedures in the lab and in animals, the most promising treatments are moved into clinical trials. As new treatments move through a series of steps called phases, more information is gained about the treatment, its risks, and its effectiveness.

What are clinical trial protocols?

Clinical trials follow a plan known as a protocol. The protocol is carefully designed to balance the potential benefits and risks to participants, and answer specific research questions. A protocol describes the following:

• The goal of the study
• Who is eligible to take part in the trial
• Protections against risks to participants
• Details about tests, procedures, and treatments
• How long the trial is expected to last
• What information will be gathered

A clinical trial is led by a principal investigator (PI). Members of the research team regularly monitor the participants’ health to determine the study’s safety and effectiveness.

What is an Institutional Review Board?

Most, but not all, clinical trials in the United States are approved and monitored by an Institutional Review Board (IRB) to ensure that the risks are reduced and are outweighed by potential benefits. IRBs are committees that are responsible for reviewing research in order to protect the rights and safety of people who take part in research, both before the research starts and as it proceeds. You should ask the sponsor or research coordinator whether the research you are thinking about joining was reviewed by an IRB.

What is a clinical trial sponsor?

Clinical trial sponsors may be people, institutions, companies, government agencies, or other organizations that are responsible for initiating, managing or financing the clinical trial, but do not conduct the research.

What is informed consent?

Informed consent is the process of providing you with key information about a research study before you decide whether to accept the offer to take part. The process of informed consent continues throughout the study. To help you decide whether to take part, members of the research team explain the details of the study. If you do not understand English, a translator or interpreter may be provided. The research team provides an informed consent document that includes details about the study, such as its purpose, how long it’s expected to last, tests or procedures that will be done as part of the research, and who to contact for further information. The informed consent document also explains risks and potential benefits. You can then decide whether to sign the document. Taking part in a clinical trial is voluntary and you can leave the study at any time.

What are the types of clinical trials?

There are different types of clinical trials.

• Prevention trials look for better ways to prevent a disease in people who have never had the disease or to prevent the disease from returning. Approaches may include medicines, vaccines, or lifestyle changes.
• Screening trials test new ways for detecting diseases or health conditions.
• Diagnostic trials study or compare tests or procedures for diagnosing a particular disease or condition.
• Treatment trials test new treatments, new combinations of drugs, or new approaches to surgery or radiation therapy.
• Behavioral trials evaluate or compare ways to promote behavioral changes designed to improve health.
• Quality of life trials (or supportive care trials) explore and measure ways to improve the comfort and quality of life of people with conditions or illnesses.

What are the phases of clinical trials?

Clinical trials are conducted in a series of steps called “phases.” Each phase has a different purpose and helps researchers answer different questions.

• Phase I trials : Researchers test a drug or treatment in a small group of people (20–80) for the first time. The purpose is to study the drug or treatment to learn about safety and identify side effects.
• Phase II trials : The new drug or treatment is given to a larger group of people (100–300) to determine its effectiveness and to further study its safety.
• Phase III trials : The new drug or treatment is given to large groups of people (1,000–3,000) to confirm its effectiveness, monitor side effects, compare it with standard or similar treatments, and collect information that will allow the new drug or treatment to be used safely.
• Phase IV trials : After a drug is approved by the FDA and made available to the public, researchers track its safety in the general population, seeking more information about a drug or treatment’s benefits, and optimal use.

What do the terms placebo, randomization, and blinded mean in clinical trials?

In clinical trials that compare a new product or therapy with another that already exists, researchers try to determine if the new one is as good, or better than, the existing one. In some studies, you may be assigned to receive a placebo (an inactive product that resembles the test product, but without its treatment value).

Comparing a new product with a placebo can be the fastest and most reliable way to show the new product’s effectiveness. However, placebos are not used if you would be put at risk — particularly in the study of treatments for serious illnesses — by not having effective therapy. You will be told if placebos are used in the study before entering a trial.

Randomization is the process by which treatments are assigned to participants by chance rather than by choice. This is done to avoid any bias in assigning volunteers to get one treatment or another. The effects of each treatment are compared at specific points during a trial. If one treatment is found superior, the trial is stopped so that the most volunteers receive the more beneficial treatment.  This video helps explain randomization for all clinical trials .

" Blinded " (or " masked ") studies are designed to prevent members of the research team and study participants from influencing the results. Blinding allows the collection of scientifically accurate data. In single-blind (" single-masked ") studies, you are not told what is being given, but the research team knows. In a double-blind study, neither you nor the research team are told what you are given; only the pharmacist knows. Members of the research team are not told which participants are receiving which treatment, in order to reduce bias. If medically necessary, however, it is always possible to find out which treatment you are receiving.

Who takes part in clinical trials?

Many different types of people take part in clinical trials. Some are healthy, while others may have illnesses. Research procedures with healthy volunteers are designed to develop new knowledge, not to provide direct benefit to those taking part. Healthy volunteers have always played an important role in research.

Healthy volunteers are needed for several reasons. When developing a new technique, such as a blood test or imaging device, healthy volunteers help define the limits of "normal." These volunteers are the baseline against which patient groups are compared and are often matched to patients on factors such as age, gender, or family relationship. They receive the same tests, procedures, or drugs the patient group receives. Researchers learn about the disease process by comparing the patient group to the healthy volunteers.

Factors like how much of your time is needed, discomfort you may feel, or risk involved depends on the trial. While some require minimal amounts of time and effort, other studies may require a major commitment of your time and effort, and may involve some discomfort. The research procedure(s) may also carry some risk. The informed consent process for healthy volunteers includes a detailed discussion of the study's procedures and tests and their risks.

A patient volunteer has a known health problem and takes part in research to better understand, diagnose, or treat that disease or condition. Research with a patient volunteer helps develop new knowledge. Depending on the stage of knowledge about the disease or condition, these procedures may or may not benefit the study participants.

Patients may volunteer for studies similar to those in which healthy volunteers take part. These studies involve drugs, devices, or treatments designed to prevent,or treat disease. Although these studies may provide direct benefit to patient volunteers, the main aim is to prove, by scientific means, the effects and limitations of the experimental treatment. Therefore, some patient groups may serve as a baseline for comparison by not taking the test drug, or by receiving test doses of the drug large enough only to show that it is present, but not at a level that can treat the condition.

Researchers follow clinical trials guidelines when deciding who can participate, in a study. These guidelines are called Inclusion/Exclusion Criteria . Factors that allow you to take part in a clinical trial are called "inclusion criteria." Those that exclude or prevent participation are "exclusion criteria." These criteria are based on factors such as age, gender, the type and stage of a disease, treatment history, and other medical conditions. Before joining a clinical trial, you must provide information that allows the research team to determine whether or not you can take part in the study safely. Some research studies seek participants with illnesses or conditions to be studied in the clinical trial, while others need healthy volunteers. Inclusion and exclusion criteria are not used to reject people personally. Instead, the criteria are used to identify appropriate participants and keep them safe, and to help ensure that researchers can find new information they need.

What do I need to know if I am thinking about taking part in a clinical trial?

Risks and potential benefits

Clinical trials may involve risk, as can routine medical care and the activities of daily living. When weighing the risks of research, you can think about these important factors:

• The possible harms that could result from taking part in the study
• The level of harm
• The chance of any harm occurring

Most clinical trials pose the risk of minor discomfort, which lasts only a short time. However, some study participants experience complications that require medical attention. In rare cases, participants have been seriously injured or have died of complications resulting from their participation in trials of experimental treatments. The specific risks associated with a research protocol are described in detail in the informed consent document, which participants are asked to consider and sign before participating in research. Also, a member of the research team will explain the study and answer any questions about the study. Before deciding to participate, carefully consider risks and possible benefits.

Potential benefits

Well-designed and well-executed clinical trials provide the best approach for you to:

• Help others by contributing to knowledge about new treatments or procedures.
• Gain access to new research treatments before they are widely available.
• Receive regular and careful medical attention from a research team that includes doctors and other health professionals.

Risks to taking part in clinical trials include the following:

• There may be unpleasant, serious, or even life-threatening effects of experimental treatment.
• The study may require more time and attention than standard treatment would, including visits to the study site, more blood tests, more procedures, hospital stays, or complex dosage schedules.

What questions should I ask if offered a clinical trial?

If you are thinking about taking part in a clinical trial, you should feel free to ask any questions or bring up any issues concerning the trial at any time. The following suggestions may give you some ideas as you think about your own questions.

• What is the purpose of the study?
• Why do researchers think the approach may be effective?
• Who will fund the study?
• Who has reviewed and approved the study?
• How are study results and safety of participants being monitored?
• How long will the study last?
• What will my responsibilities be if I take part?
• Who will tell me about the results of the study and how will I be informed?

Risks and possible benefits

• What are my possible short-term benefits?
• What are my possible long-term benefits?
• What are my short-term risks, and side effects?
• What are my long-term risks?
• What other options are available?
• How do the risks and possible benefits of this trial compare with those options?

Participation and care

• What kinds of therapies, procedures and/or tests will I have during the trial?
• Will they hurt, and if so, for how long?
• How do the tests in the study compare with those I would have outside of the trial?
• Will I be able to take my regular medications while taking part in the clinical trial?
• Where will I have my medical care?
• Who will be in charge of my care?

Personal issues

• How could being in this study affect my daily life?
• Can I talk to other people in the study?

Cost issues

• Will I have to pay for any part of the trial such as tests or the study drug?
• If so, what will the charges likely be?
• What is my health insurance likely to cover?
• Who can help answer any questions from my insurance company or health plan?
• Will there be any travel or child care costs that I need to consider while I am in the trial?

Tips for asking your doctor about trials

• Consider taking a family member or friend along for support and for help in asking questions or recording answers.
• Plan what to ask — but don't hesitate to ask any new questions.
• Write down questions in advance to remember them all.
• Write down the answers so that they’re available when needed.
• Ask about bringing a tape recorder to make a taped record of what's said (even if you write down answers).

This information courtesy of Cancer.gov.

How is my safety protected?

Ethical guidelines

The goal of clinical research is to develop knowledge that improves human health or increases understanding of human biology. People who take part in clinical research make it possible for this to occur. The path to finding out if a new drug is safe or effective is to test it on patients in clinical trials. The purpose of ethical guidelines is both to protect patients and healthy volunteers, and to preserve the integrity of the science.

Informed consent

Informed consent is the process of learning the key facts about a clinical trial before deciding whether to participate. The process of providing information to participants continues throughout the study. To help you decide whether to take part, members of the research team explain the study. The research team provides an informed consent document, which includes such details about the study as its purpose, duration, required procedures, and who to contact for various purposes. The informed consent document also explains risks and potential benefits.

If you decide to enroll in the trial, you will need to sign the informed consent document. You are free to withdraw from the study at any time.

Most, but not all, clinical trials in the United States are approved and monitored by an Institutional Review Board (IRB) to ensure that the risks are minimal when compared with potential benefits. An IRB is an independent committee that consists of physicians, statisticians, and members of the community who ensure that clinical trials are ethical and that the rights of participants are protected. You should ask the sponsor or research coordinator whether the research you are considering participating in was reviewed by an IRB.

Further reading

For more information about research protections, see:

• Office of Human Research Protection
• Children's Assent to Clinical Trial Participation

For more information on participants’ privacy and confidentiality, see:

• HIPAA Privacy Rule
• The Food and Drug Administration, FDA’s Drug Review Process: Ensuring Drugs Are Safe and Effective

For more information about research protections, see: About Research Participation

What happens after a clinical trial is completed?

After a clinical trial is completed, the researchers carefully examine information collected during the study before making decisions about the meaning of the findings and about the need for further testing. After a phase I or II trial, the researchers decide whether to move on to the next phase or to stop testing the treatment or procedure because it was unsafe or not effective. When a phase III trial is completed, the researchers examine the information and decide whether the results have medical importance.

Results from clinical trials are often published in peer-reviewed scientific journals. Peer review is a process by which experts review the report before it is published to ensure that the analysis and conclusions are sound. If the results are particularly important, they may be featured in the news, and discussed at scientific meetings and by patient advocacy groups before or after they are published in a scientific journal. Once a new approach has been proven safe and effective in a clinical trial, it may become a new standard of medical practice.

Ask the research team members if the study results have been or will be published. Published study results are also available by searching for the study's official name or Protocol ID number in the National Library of Medicine's PubMed® database .

How does clinical research make a difference to me and my family?

Only through clinical research can we gain insights and answers about the safety and effectiveness of treatments and procedures. Groundbreaking scientific advances in the present and the past were possible only because of participation of volunteers, both healthy and those with an illness, in clinical research. Clinical research requires complex and rigorous testing in collaboration with communities that are affected by the disease. As research opens new doors to finding ways to diagnose, prevent, treat, or cure disease and disability, clinical trial participation is essential to help us find the answers.

This page last reviewed on October 3, 2022

Connect with Us

• More Social Media from NIH